← Eichor
Condition: Chronic Obstructive Pulmonary Disease Moderate Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chronic Obstructive Pulmonary Disease Moderate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
Phase 2 · 2 location(s) · Meribank Biotech Co., Ltd. · NCT06491043Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo
Phase N/A · 36 location(s) · AstraZeneca · NCT07069829A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · 301 location(s) · AstraZeneca · NCT06883305Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive P
Phase 4 · 5 location(s) · AstraZeneca · NCT06531798Acute Effect of Different Frequency of Whole Body Vibration (WBV) on Healthy and Chronic Obstructive Pulmonary Disease (
NA · 1 location(s) · National Cheng Kung University · NCT07509606Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 159 location(s) · GlaxoSmithKline · NCT06961214Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease
Phase N/A · 1 location(s) · Lithuanian University of Health Sciences · NCT06072690A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · 12 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmo
Phase 2/Phase 3 · 103 location(s) · Pfizer · NCT07363694A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Phase 2 · 4 location(s) · Windward Bio · NCT07646587A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT07418736A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · 268 location(s) · AstraZeneca · NCT06878261Phase II Study of RC1416 Injection in COPD
Phase 2 · 42 location(s) · Nanjing RegeneCore Biotech Co., Ltd. · NCT07402551Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
Phase N/A · 1 location(s) · Gelb, Arthur F., M.D. · NCT00576069Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 15 location(s) · GlaxoSmithKline · NCT06959095A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease
NA · 1 location(s) · Novlead Inc. · NCT07382258Continuous Versus High Intensity Interval Exercise in Chronic Obstructive Pulmonary Disease
NA · 1 location(s) · George Papanicolaou Hospital · NCT07707271A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05896800A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Phase 2 · 33 location(s) · Sanofi · NCT07116031DUET Versus Standard Interface for Hypercapnic COPD Patients
NA · 2 location(s) · Larissa University Hospital · NCT05829083A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD
Phase 2 · 1 location(s) · Joincare Pharmaceutical Group Industry Co., Ltd · NCT07351734A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · 368 location(s) · AstraZeneca · NCT07082738Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in COPD-pa
NA · 2 location(s) · Eastern Switzerland University of Applied Sciences · NCT07063563Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 3 · 4 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07039669
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.